Tag: Chemotherapy
Continuing Full Induction Regimen Not Beneficial in Metastatic CRC
Maintenance therapy shows benefit versus observation in terms of PFS but not overall survival
SABCS: Addition of Tucatinib Ups Survival in HER2+ Metastatic Breast Cancer
In heavily pretreated patients, adding tucatinib versus placebo improves overall, progression-free survival
ASH: PET Helps Tailor Therapy in Limited-Stage DLBCL
Most patients had negative PET scan and completed one additional R-CHOP cycle without radiation
Endocrine Therapy Lowers QOL for Breast Cancer Patients
Effects of chemotherapy found to be more transient in comparison
Secondary Surgical Cytoreduction Not Superior in Ovarian Cancer
Addition of surgery prior to chemotherapy does not prolong overall survival in recurrent ovarian cancer
Gilteritinib Superior in Relapsed, Refractory FLT3-Mutated AML
Overall survival significantly longer, percentage of remission higher than with salvage chemotherapy
Full Chemo Doses May Improve Survival in Breast Cancer
Maintaining full doses of chemo especially important early in the treatment course
Algorithm Based on Response, Biology Guides Neuroblastoma Tx
Survival excellent with treatment algorithm for children with intermediate-risk neuroblastoma
Salvage Therapy Does Not Up Survival for Progressive Myeloma
Deepening of response through salvage therapy not linked to improved progression-free, overall survival
Risk for Cardiovascular Disease Greater for Childhood Cancer Survivors
Exposure to ≥250 mg/m² doxorubicin-equivalent anthracycline chemo tied to risk for CVD, heart failure
